Hengxing Chen

739 total citations · 1 hit paper
19 papers, 516 citations indexed

About

Hengxing Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hengxing Chen has authored 19 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Hengxing Chen's work include Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Hengxing Chen is often cited by papers focused on Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Hengxing Chen collaborates with scholars based in China, United States and Singapore. Hengxing Chen's co-authors include Kaishun Hu, Dong Yin, Yulong He, Yu Li, Leli Zeng, H. Phillip Koeffler, Zhen Chen, Yin Zhang, Wenjing Wu and Huashan Liu and has published in prestigious journals such as Nature, Advanced Materials and ACS Nano.

In The Last Decade

Hengxing Chen

19 papers receiving 512 citations

Hit Papers

Exosome circATP8A1 induces macrophage M2 polarization by ... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hengxing Chen China 13 309 149 120 71 69 19 516
Panpan Zhan China 9 376 1.2× 180 1.2× 122 1.0× 58 0.8× 69 1.0× 11 509
Heng Lu United States 16 368 1.2× 160 1.1× 145 1.2× 42 0.6× 86 1.2× 32 629
Shan Pan China 14 421 1.4× 253 1.7× 100 0.8× 35 0.5× 95 1.4× 30 671
Qianwei Ye China 11 253 0.8× 219 1.5× 126 1.1× 53 0.7× 38 0.6× 15 511
Yanwen Zheng China 13 209 0.7× 104 0.7× 74 0.6× 58 0.8× 58 0.8× 27 425
Leping Yang China 17 398 1.3× 229 1.5× 195 1.6× 67 0.9× 46 0.7× 41 725
Yuheng Yan China 9 221 0.7× 128 0.9× 219 1.8× 63 0.9× 169 2.4× 15 585
Karolina Weiner‐Gorzel Ireland 5 416 1.3× 250 1.7× 180 1.5× 53 0.7× 77 1.1× 7 587
Joel Encarnación-Rosado United States 9 358 1.2× 292 2.0× 182 1.5× 71 1.0× 63 0.9× 12 591
Huijing Yin China 10 286 0.9× 141 0.9× 142 1.2× 27 0.4× 108 1.6× 16 523

Countries citing papers authored by Hengxing Chen

Since Specialization
Citations

This map shows the geographic impact of Hengxing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengxing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengxing Chen more than expected).

Fields of papers citing papers by Hengxing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hengxing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengxing Chen. The network helps show where Hengxing Chen may publish in the future.

Co-authorship network of co-authors of Hengxing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hengxing Chen. A scholar is included among the top collaborators of Hengxing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengxing Chen. Hengxing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Huafu, Linxiang Lan, Hengxing Chen, et al.. (2025). SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer. Nature. 648(8092). 203–209. 1 indexed citations
2.
Fu, Huafeng, Jie Zhang, Hengxing Chen, et al.. (2025). NPR1 Promotes Lipid Droplet Lipolysis to Enhance Mitochondrial Oxidative Phosphorylation and Fuel Gastric Cancer Metastasis. Advanced Science. 12(37). e03233–e03233. 4 indexed citations
3.
Huo, Mingyu, Xiaomei Zhuang, Wenchao Li, et al.. (2024). Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression. Molecular Cancer. 23(1). 49–49. 82 indexed citations breakdown →
4.
Peng, Li, Yan‐Yi Jiang, Hengxing Chen, et al.. (2024). Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma. Acta Pharmaceutica Sinica B. 14(5). 2119–2136. 2 indexed citations
5.
Mao, Deli, Zhijun Zhou, Hengxing Chen, et al.. (2023). Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer. Cancer Letters. 572. 216351–216351. 26 indexed citations
6.
Chen, Xiancong, Deli Mao, Dongsheng Li, et al.. (2023). Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer. Journal of Cancer Research and Clinical Oncology. 149(9). 5871–5884. 1 indexed citations
7.
Li, Yun, Hengxing Chen, Xuan Xie, et al.. (2022). PINK1-Mediated Mitophagy Promotes Oxidative Phosphorylation and Redox Homeostasis to Induce Drug-Tolerant Persister Cancer Cells. Cancer Research. 83(3). 398–413. 79 indexed citations
8.
Liu, Shikai, Wenting Li, Hengxing Chen, et al.. (2022). On-Demand Generation of Peroxynitrite from an Integrated Two-Dimensional System for Enhanced Tumor Therapy. ACS Nano. 16(6). 8939–8953. 56 indexed citations
9.
Wang, Yinzhao, et al.. (2022). Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence. Medical Oncology. 39(12). 185–185. 10 indexed citations
10.
Li, Jia, Leli Zeng, Zheng Wang, et al.. (2021). Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers. Advanced Materials. 34(1). e2100245–e2100245. 46 indexed citations
11.
Mao, Deli, Rui Xu, Hengxing Chen, et al.. (2021). Cross-Talk of Focal Adhesion-Related Gene Defines Prognosis and the Immune Microenvironment in Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 716461–716461. 16 indexed citations
12.
Chen, Hengxing, Yun Li, Yu Li, et al.. (2020). PARK2 promotes mitochondrial pathway of apoptosis and antimicrotubule drugs chemosensitivity via degradation of phospho-BCL-2. Theranostics. 10(22). 9984–10000. 15 indexed citations
13.
Zheng, Dandan, Yuchuan Jiang, Chen Qu, et al.. (2020). Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis. American Journal Of Pathology. 190(11). 2267–2281. 50 indexed citations
14.
Chen, Hengxing & Chun Liu. (2020). Research on Knee Injuries in College Football Training Based on Artificial Neural Network. 32. 35–37. 2 indexed citations
15.
Li, Yu, Xing Xiao, Hengxing Chen, et al.. (2020). Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma.. PubMed. 10(8). 2446–2463. 19 indexed citations
16.
Hu, Kaishun, Wenjing Wu, Yu Li, et al.. (2019). Poly( ADP ‐ribosyl)ation of BRD 7 by PARP 1 confers resistance to DNA ‐damaging chemotherapeutic agents. EMBO Reports. 20(5). 45 indexed citations
17.
Chen, Zhen, Wenjing Wu, Yongsheng Huang, et al.. (2019). RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. Journal of Cancer. 10(27). 6837–6847. 30 indexed citations
18.
Hu, Kaishun, Yu Li, Wenjing Wu, et al.. (2018). High-performance gene expression and knockout tools using sleeping beauty transposon system. Mobile DNA. 9(1). 33–33. 20 indexed citations
19.
Li, Yu, Kaishun Hu, Xing Xiao, et al.. (2018). FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation. Biochemical and Biophysical Research Communications. 497(2). 473–479. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026